CCL23



CCL23

R1RR1V2VV2T3TT3K4KK4D5DD5A6AA6E7EE7T8TT8E9EE9F10FF10M11MM11M12MM12S13SS13K14KK14L15LL15P16PP16L17LL17E18EE18N19NN19P20PP20V21VV21L22LL22L23LL23D24DD24R25RR25F26FF26H27HH27A28AA28T29TT29S30SS30A31AA31D32DD32C33CC33C34CC34I35II35S36SS36Y37YY37T38TT38P39PP39R40RR40S41SS41I42II42P43PP43C44CC44S45SS45L46LL46L47LL47... and 52 more residue(s)...... and 52 more residue(s)

SMILES None
InChIKey None
Sequence RVTKDAETEFMMSKLPLENPVLLDRFHATSADCCISYTPRSIPCSLLESYFETNSECSKPGVIFLTKKGRRFCANPSDKQVQVCMRMLKLDTRIKTRKN

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

CCL23

R1RR1V2VV2T3TT3K4KK4D5DD5A6AA6E7EE7T8TT8E9EE9F10FF10M11MM11M12MM12S13SS13K14KK14L15LL15P16PP16L17LL17E18EE18N19NN19P20PP20V21VV21L22LL22L23LL23D24DD24R25RR25F26FF26H27HH27A28AA28T29TT29S30SS30A31AA31D32DD32C33CC33C34CC34I35II35S36SS36Y37YY37T38TT38P39PP39R40RR40S41SS41I42II42P43PP43C44CC44S45SS45L46LL46L47LL47... and 52 more residue(s)...... and 52 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.